Cargando…
Increased sensitivity to platinum drugs of cancer cells with acquired resistance to trabectedin
BACKGROUND: In order to investigate the mechanisms of acquired resistance to trabectedin, trabectedin-resistant human myxoid liposarcoma (402-91/T) and ovarian carcinoma (A2780/T) cell lines were derived and characterised in vitro and in vivo. METHODS: Resistant cell lines were obtained by repeated...
Autores principales: | Colmegna, B, Uboldi, S, Frapolli, R, Licandro, S A, Panini, N, Galmarini, C M, Badri, Nadia, Spanswick, V J, Bingham, J P, Kiakos, Konstantinos, Erba, E, Hartley, J A, D'Incalci, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701998/ https://www.ncbi.nlm.nih.gov/pubmed/26633559 http://dx.doi.org/10.1038/bjc.2015.407 |
Ejemplares similares
-
Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms
por: Romano, Michela, et al.
Publicado: (2017) -
Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models
por: Belgiovine, Cristina, et al.
Publicado: (2017) -
Trabectedin, a drug acting on both cancer cells and the tumour microenvironment
por: D'Incalci, M, et al.
Publicado: (2014) -
Mechanism of action of trabectedin in desmoplastic small round cell tumor cells
por: Uboldi, S., et al.
Publicado: (2017) -
Trabectedin and Plitidepsin: Drugs from the Sea that Strike the Tumor Microenvironment
por: Galmarini, Carlos M., et al.
Publicado: (2014)